SUBSCRIBE
SUBSCRIBE
News   Deals

Targacept, Inc. Sets IPO At 5 Million Shares, $11-$13/Share

March 16, 2006 | 
1 min read

WASHINGTON, March 16 (Reuters) - Biopharmaceutical company Targacept Inc. on Thursday set its planned initial public offering at 5 million shares for between $11 and $13 per share.

IPO
MORE ON THIS TOPIC
Reaching an agreement. Businessmen shake hands and make a deal. vector
GLP-1
Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
November 4, 2024
 · 
1 min read
 · 
Annalee Armstrong
Pictured: Biogen's signage at its headquarters in Massachusetts
Earnings
Biogen Tops Wall Street Expectations for Leqembi, Inks Molecular Glue Deal
October 30, 2024
 · 
2 min read
 · 
Heather McKenzie
Podcast
Pfizer’s Q3 Earnings Win, Deals Galore, Countdown to Election, More
October 30, 2024
 · 
1 min read
 · 
Heather McKenzie
Human hand showing modern buildings and skyscrapers with a colored background. Collage art
NextGen
10 Years of NextGen Honorees: Where Are They Now?
October 30, 2024
 · 
8 min read
 · 
Annalee Armstrong